The Georgia Senate overwhelmingly passed a medical marijuana measure Friday that would allow only a very limited form of the drug to be used in clinical trials involving children with epilepsy.
Senate Bill 185 is one of two medical marijuana bills being considered this year in the state Legislature. It differs dramatically from its counterpart, House Bill 1, which is much broader and would make it legal for someone with a doctor’s prescription to possess limited amounts of cannibis oil to treat more than half a dozen disorders, including cancer, Parkinson’s disease and sickle cell disease.
SB 185’s sponsor, state Sen. Lindsey Tippins, R-Marietta, said he believes it is the safest way to introduce the use of cannabis oil in Georgia — doing so under strict medical supervision in a four-year clinical trial overseen by the federal Food and Drug Administration. On Friday, however, he said he would be willing to expand his measure to include more disorders.